SCHEMBL981005

SCHEMBL981005

O=C(Cc1ccccn1)N1CCC(c2ccc(Cl)s2)=N1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
KMT2A Q03164 3/20 0.46
MEN1 O00255 1/20 0.46
MAPT P10636 1/20 0.46
CNR1 P21554 1/20 0.43
HPGD P15428 1/20 0.43
L3MBTL1 Q9Y468 3/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
SLC6A7 Q99884 1/20 0.38
FNTA P49354 2/20 0.38
FNTB P49356 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
KDM4E B2RXH2 2/20 0.37
SIGMAR1 Q99720 1/20 0.36
TP53 P04637 1/20 0.36
CASP3 P42574 1/20 0.36
SENP8 Q96LD8 1/20 0.36
SENP7 Q9BQF6 1/20 0.36
SENP6 Q9GZR1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL981256 0.78 ALDH1A1 (0.48) ALDH1A1KMT2AMEN1MAPTHPGD
SCHEMBL983020 0.76 FNTA (0.47) ALDH1A1KMT2ACNR1HPGDNPC1
SCHEMBL979274 0.75 KMT2A (0.45) ALDH1A1KMT2AMEN1MAPTHPGD
SCHEMBL981671 0.74 MEN1 (0.47) ALDH1A1KMT2AMEN1MAPTHPGD
SCHEMBL982252 0.73 ALDH1A1 (0.43) ALDH1A1KMT2AMEN1MAPTHPGD
SCHEMBL981423 0.73 ALDH1A1 (0.43) ALDH1A1KMT2AMEN1MAPTHPGD
SCHEMBL979314 0.72 LMNA (0.46) ALDH1A1KMT2AMEN1MAPTCNR1
SCHEMBL983189 0.71 POLB (0.44) ALDH1A1KMT2AMEN1MAPTHPGD
SCHEMBL981944 0.71 PHGDH (0.44) ALDH1A1KMT2AMEN1MAPTHPGD
SCHEMBL980584 0.70 GAA (0.45) ALDH1A1KMT2AMEN1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1917248-B1 1-ACYLDIHYDROPYRAZOL DERIVATIVES MERCK PATENT GMBH (DE) 2015-08-19 EP claimed
US-7875644-B2 tyrosine kinase inhibitors, in particular Met kinase; antitumor agents;1-(Benzo-1,2,5-thiadiazol-5-ylmethylcarbonyl)-3-(2,4-dimethoxyphenyl)-4,5-dihydro-1H-pyrazole; leukemia, carcinomas MERCK PATENT GMBH (DE) 2011-01-25 US claimed
US-20080249095-A1 1-Acyldihydropyrazole Derivatives MERCK PATENT GESELLSCHAFT (DE) 2008-10-09 US claimed
EP-1917248-B1 1-ACYLDIHYDROPYRAZOL DERIVATIVES MERCK PATENT GMBH (DE) 2015-08-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080249095-A1 1-Acyldihydropyrazole Derivatives MET, FLT3, ERBB3 ALDH1A1 399/4885KMT2A 174/4885MEN1 221/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.